RT Journal Article
T1 The Impact of Surgical Practice on Oncological Outcomes in Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer, Spanish National Registry.
A1 Fernandez-Gonzalez, Sergi
A1 Ponce, Jordi
A1 Martínez-Maestre, María Ángeles
A1 Barahona, Marc
A1 Gómez-Hidalgo, Natalia R
A1 Díaz-Feijoo, Berta
A1 Casajuana, Andrea
A1 Gracia, Myriam
A1 Frias-Gomez, Jon
A1 Benavente, Yolanda
A1 Costas, Laura
A1 Martí, Lola
A1 Melero, Lidia
A1 Silvan, Jose Manuel
A1 Beiro, Eva
A1 Lobo, Ignacio
A1 De la Rosa, Jesús
A1 Coronado, Pluvio J
A1 Gil-Moreno, Antonio
K1 disease-free survival
K1 early-stage cervical cancer
K1 oncological outcome
K1 radical hysterectomy
K1 recurrence
K1 robotic surgery
K1 surgery
K1 surgical practice
AB This study aimed to assess whether surgical practice had a significant impact on oncological outcomes among women who underwent robot-assisted radical hysterectomy for early-stage cervical cancer (≤IB1 or IIA1, FIGO 2009). The secondary objective was to audit the pre-surgical quality indicators (QI) proposed by the European Society of Gynaecological Oncology (ESGO). The top 5 of 10 centers in Spain and Portugal were included in the analysis. The hospitals were divided into group A (n = 118) and group B (n = 97), with recurrence rates of 10%, respectively. After balancing both groups using the propensity score, the ORs for all events were higher and statistically significant for group B (recurrences OR = 1.23, 95% CI = 1.13-1.15, p-value = 0.001; death OR = 1.10, 95% CI = 1.02-1.18, p-value = 0.012; disease-specific mortality ORr = 1.11, 95% CI = 1.04-1.19, p-value = 0.002). A higher surgical volume, higher participation in clinical trials, higher rate of MRI use for diagnosis, greater use of sentinel lymph node biopsies, and a favorable learning curve with low rates of early recurrences were observed among the centers with better oncological outcomes. These factors might have a significant impact on oncological outcomes not only after robot-assisted surgery, but also after laparoscopies and open surgeries in the treatment of cervical cancer.
SN 2072-6694
YR 2022
FD 2022-01-29
LK http://hdl.handle.net/10668/20871
UL http://hdl.handle.net/10668/20871
LA en
DS RISalud
RD Apr 18, 2025